1ke7: Difference between revisions

Line 4:

==Overview==

Two closely related classes of oxindole-based compounds, 1H-indole-2,3-dione 3-phenylhydrazones and, 3-(anilinomethylene)-1,3-dihydro-2H-indol-2-ones, were shown to potently, inhibit cyclin-dependent kinase 2 (CDK2). The initial lead compound was, prepared as a homologue of the 3-benzylidene-1,3-dihydro-2H-indol-2-one, class of kinase inhibitor. Crystallographic analysis of the lead compound, bound to CDK2 provided the basis for analogue design. A semiautomated, method of ligand docking was used to select compounds for synthesis, and a, number of compounds with low nanomolar inhibitory activity versus CDK2, were identified. Enzyme binding determinants for several analogues were, evaluated by X-ray crystallography. Compounds in this series inhibited, CDK2 with a potency approximately 10-fold greater than that for CDK1., Members of this class of inhibitor cause an arrest of the cell cycle and, have shown potential utility in the prevention of chemotherapy-induced, alopecia.

Two closely related classes of oxindole-based compounds, 1H-indole-2,3-dione 3-phenylhydrazones and 3-(anilinomethylene)-1,3-dihydro-2H-indol-2-ones, were shown to potently inhibit cyclin-dependent kinase 2 (CDK2). The initial lead compound was prepared as a homologue of the 3-benzylidene-1,3-dihydro-2H-indol-2-one class of kinase inhibitor. Crystallographic analysis of the lead compound bound to CDK2 provided the basis for analogue design. A semiautomated method of ligand docking was used to select compounds for synthesis, and a number of compounds with low nanomolar inhibitory activity versus CDK2 were identified. Enzyme binding determinants for several analogues were evaluated by X-ray crystallography. Compounds in this series inhibited CDK2 with a potency approximately 10-fold greater than that for CDK1. Members of this class of inhibitor cause an arrest of the cell cycle and have shown potential utility in the prevention of chemotherapy-induced alopecia.

==About this Structure==

Line 14:

[[Category: Non-specific serine/threonine protein kinase]]

[[Category: Single protein]]

[[Category: Bramson, H.N.]]

[[Category: Bramson, H N.]]

[[Category: Corona, J.]]

[[Category: Davis, S.T.]]

[[Category: Davis, S T.]]

[[Category: Dickerson, S.H.]]

[[Category: Dickerson, S H.]]

[[Category: Edelstein, M.]]

[[Category: Frye, S.V.]]

[[Category: Frye, S V.]]

[[Category: Gampe, R.T.]]

[[Category: Gampe, R T.]]

[[Category: Hassell, A.H.]]

[[Category: Hassell, A H.]]

[[Category: Kuyper, L.F.]]

[[Category: Kuyper, L F.]]

[[Category: Shewchuk, L.M.]]

[[Category: Shewchuk, L M.]]

[[Category: LS3]]

[[Category: cyclin]]

[[Category: kinase]]

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on ~~Fri~~ Feb ~~15 16~~:12:56 2008''

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:33:06 2008''

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 4: / Line 4: @@
 ==Overview==
-Two closely related classes of oxindole-based compounds, 1H-indole-2,3-dione 3-phenylhydrazones and, 3-(anilinomethylene)-1,3-dihydro-2H-indol-2-ones, were shown to potently, inhibit cyclin-dependent kinase 2 (CDK2). The initial lead compound was, prepared as a homologue of the 3-benzylidene-1,3-dihydro-2H-indol-2-one, class of kinase inhibitor. Crystallographic analysis of the lead compound, bound to CDK2 provided the basis for analogue design. A semiautomated, method of ligand docking was used to select compounds for synthesis, and a, number of compounds with low nanomolar inhibitory activity versus CDK2, were identified. Enzyme binding determinants for several analogues were, evaluated by X-ray crystallography. Compounds in this series inhibited, CDK2 with a potency approximately 10-fold greater than that for CDK1., Members of this class of inhibitor cause an arrest of the cell cycle and, have shown potential utility in the prevention of chemotherapy-induced, alopecia.
+Two closely related classes of oxindole-based compounds, 1H-indole-2,3-dione 3-phenylhydrazones and 3-(anilinomethylene)-1,3-dihydro-2H-indol-2-ones, were shown to potently inhibit cyclin-dependent kinase 2 (CDK2). The initial lead compound was prepared as a homologue of the 3-benzylidene-1,3-dihydro-2H-indol-2-one class of kinase inhibitor. Crystallographic analysis of the lead compound bound to CDK2 provided the basis for analogue design. A semiautomated method of ligand docking was used to select compounds for synthesis, and a number of compounds with low nanomolar inhibitory activity versus CDK2 were identified. Enzyme binding determinants for several analogues were evaluated by X-ray crystallography. Compounds in this series inhibited CDK2 with a potency approximately 10-fold greater than that for CDK1. Members of this class of inhibitor cause an arrest of the cell cycle and have shown potential utility in the prevention of chemotherapy-induced alopecia.
 ==About this Structure==
@@ Line 14: / Line 14: @@
 [[Category: Non-specific serine/threonine protein kinase]]
 [[Category: Single protein]]
-[[Category: Bramson, H.N.]]
+[[Category: Bramson, H N.]]
 [[Category: Corona, J.]]
-[[Category: Davis, S.T.]]
+[[Category: Davis, S T.]]
-[[Category: Dickerson, S.H.]]
+[[Category: Dickerson, S H.]]
 [[Category: Edelstein, M.]]
-[[Category: Frye, S.V.]]
+[[Category: Frye, S V.]]
-[[Category: Gampe, R.T.]]
+[[Category: Gampe, R T.]]
-[[Category: Hassell, A.H.]]
+[[Category: Hassell, A H.]]
-[[Category: Kuyper, L.F.]]
+[[Category: Kuyper, L F.]]
-[[Category: Shewchuk, L.M.]]
+[[Category: Shewchuk, L M.]]
 [[Category: LS3]]
 [[Category: cyclin]]
 [[Category: kinase]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:12:56 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:33:06 2008''